European shares extended their fall on Tuesday, Reuters reported. The pan-European STOXX 600 benchmark dropped 0.4 percent, falling for a second session, while euro zone stocks and blue-chips followed suit. The greatest downward pull came from healthcare stocks. Swiss drugmaker Roche fell 4.5 percent after investors were disappointed by findings in its Aphinity study for a key breast cancer treatment. The euro has gained 5.6 percent against the dollar over the past two months. Among the handful of gainers, Vestas Wind rose 2.9 percent after MHI Vestas, a joint venture with Mitsubishi Heavy Industries, said it was launching a new wind turbine. Also among top gainers was Lufthansa, rising 2.6 percent after the German carrier's CEO said he was optimistic on demand and improving traffic from the United States and Asia.
